Domperidone and Risk of Sudden Cardiac Death

CompletedOBSERVATIONAL
Enrollment

214,962

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Parkinson's Disease
Interventions
DRUG

Domperidone

"Current exposure to domperidone will be defined as a prescription dispensed within 30 days before the index date.~Recent exposure to domperidone will be defined as a prescription dispensed between 31 and 90 days before the index date (without a dispensing during the 30 days period preceding index date).~Past exposure to domperidone will be defined as a prescription dispensed between 91 and 365 days before the index date (without prescription in the 90 days period prior index date)."

Trial Locations (1)

H3T1E2

Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

Drug Safety and Effectiveness Network, Canada

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Canadian Network for Observational Drug Effect Studies, CNODES

OTHER

NCT02500108 - Domperidone and Risk of Sudden Cardiac Death | Biotech Hunter | Biotech Hunter